The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored.
Alessandro GambellaSilvia KalantariMassimiliano CadamuroMarco QuagliaMaurizio DelvecchioLuca FabrisMichele PinonPublished in: Cells (2023)
The hepatocyte nuclear factor 1β (HNF1B) gene is involved in the development of specialized epithelia of several organs during the early and late phases of embryogenesis, performing its function mainly by regulating the cell cycle and apoptosis pathways. The first pathogenic variant of HNF1B (namely, R177X) was reported in 1997 and is associated with the maturity-onset diabetes of the young. Since then, more than 230 different HNF1B variants have been reported, revealing a multifaceted syndrome with complex and heterogenous genetic, pathologic, and clinical profiles, mainly affecting the pediatric population. The pancreas and kidneys are the most frequently affected organs, resulting in diabetes, renal cysts, and a decrease in renal function, leading, in 2001, to the definition of HNF1B deficiency syndrome, including renal cysts and diabetes. However, several other organs and systems have since emerged as being affected by HNF1B defect, while diabetes and renal cysts are not always present. Especially, liver involvement has generally been overlooked but recently emerged as particularly relevant (mostly showing chronically elevated liver enzymes) and with a putative relation with tumor development, thus requiring a more granular analysis. Nowadays, HNF1B-associated disease has been recognized as a clinical entity with a broader and more variable multisystem phenotype, but the reasons for the phenotypic heterogeneity are still poorly understood. In this review, we aimed to describe the multifaceted nature of HNF1B deficiency in the pediatric and adult populations: we analyzed the genetic, phenotypic, and clinical features of this complex and misdiagnosed syndrome, covering the most frequent, unusual, and recently identified traits.
Keyphrases
- nuclear factor
- toll like receptor
- type diabetes
- cell cycle
- cardiovascular disease
- genome wide
- glycemic control
- copy number
- case report
- cell proliferation
- oxidative stress
- palliative care
- single cell
- squamous cell carcinoma
- immune response
- inflammatory response
- replacement therapy
- radiation therapy
- cell death
- lymph node
- dna methylation
- metabolic syndrome
- insulin resistance
- transcription factor
- locally advanced